Surgeons discuss the current paradigm for adult congenital heart disease surgery and outline recommendations to strengthen the subspecialty.
Pediatric cardiologist Gerald Boyle, MD, discusses a complex case involving a young patient with concurrent congenital heart defects and eventual heart transplant.
Cleveland Clinic experts combined advanced imaging techniques with histology to reveal aortic root position and features, which could give surgeons new tools for surgical planning and improved outcomes.
A novel surgical risk model specific to patients with adult congenital heart disease is a much-needed addition to previous tools for predicting 30-day postoperative survival in this growing population.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Since it first launched in 2021, the Pediatric and Adult Congenital Heart Center has provided a new construct for delivering treatment options to adults and children with complex congenital cardiovascular issues.
Nearly half of families of children with congenital heart disease face financial hardship from medical bills and associated expenses, which can lead to food insecurity and delayed care. Pediatric and congenital heart surgeon Tara Karamlou, MD, MSc, suggests ways to address these issues.
Challenging cases of congenital heart disease require systematic planning, multiple backup plans, a readiness to become aggressive and more. A veteran surgeon shares tips and two illustrative cases.
Congenitally corrected transposition of the great arteries is a rare anomaly with no single best answer for every patient. But a new analysis of one of the largest series to date should help shape management strategies.
Thanks to advances in medical and surgical management of congenital heart disease, many patients are living longer and require the full continuum of care from fetal diagnosis through adulthood. This comprehensive multidisciplinary symposium on congenital heart disease across the lifespan draws on broad subspecialty expertise to address a host of nuanced issues.
Biomedical engineers have developed a self-regulating pediatric continuous-flow total artificial heart that is small enough to be placed in infants. The device, which is still being tested, holds promise but faces challenges. Kioytaka Fukamachi, MD, PhD, explains how the device works, the challenges specific to creating and marketing the device, and his lab’s next steps.